Manufacturer copay assistance · Ogivri (Q5114) · Biocon Biologics
Commercially insured… · Covers Ogivri drug cost only — administration billed separately
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
No foundation fund in our catalog currently matches Ogivri — check the full fund board.
Run a benefits estimate for Ogivri — the program's cap applies against the patient share CareCost calculates.
Yes — My Biocon Biologics Patient Support Program — Copay Assistance from Biocon Biologics. Commercially insured patients may access Ogivri with a copay as low as $0 — eligibility requirements apply. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Commercially insured patients may access Ogivri with a copay as low as $0 — eligibility requirements apply Maximum benefit: not published. Covers Ogivri drug cost only — administration billed separately
Accepted insurance: commercial. Not eligible: medicare, medicaid, medicare_part_d, medigap, government.